| Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic SA Mendonça, R Lorincz, P Boucher, DT Curiel npj Vaccines 6 (1), 97, 2021 | 247 | 2021 |
| Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy RFV Medrano, A Hunger, SA Mendonça, JAM Barbuto, BE Strauss Oncotarget 8 (41), 71249, 2017 | 189 | 2017 |
| Interleukin‐6 c.‐174G> C Polymorphism and periodontitis in a Brazilian population F Gabriela Teixeira, SA Mendonça, K Menezes Oliveira, ... Molecular Biology International 2014 (1), 490308, 2014 | 38 | 2014 |
| Subverted regulation of Nox1 NADPH oxidase-dependent oxidant generation by protein disulfide isomerase A1 in colon carcinoma cells with overactivated KRas TC De Bessa, A Pagano, AIS Moretti, PVS Oliveira, SA Mendonça, ... Cell Death & Disease 10 (2), 143, 2019 | 22 | 2019 |
| Study of the association between the interleukin-1 β c. 3954C> T polymorphism and periodontitis in a population sample from Bahia, Brazil SA Mendonça, FG Teixeira, KM Oliveira, DB Santos, LM Marques, ... Contemporary clinical dentistry 6 (2), 176-182, 2015 | 15 | 2015 |
| Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation OLD Cerqueira, MA Clavijo-Salomon, EC Cardoso, ... Frontiers in immunology 11, 576658, 2020 | 11 | 2020 |
| Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death PR Del Valle, SA Mendonça, F Antunes, A Hunger, RE Tamura, ... Cancer Biology & Therapy 22 (4), 301-310, 2021 | 7 | 2021 |
| Targeting tumor neoangiogenesis via targeted adenoviral vector to achieve effective cancer gene therapy for disseminated neoplastic disease M Lee, ZH Lu, J Li, EA Kashentseva, IP Dmitriev, SA Mendonca, DT Curiel Molecular cancer therapeutics 19 (3), 966-971, 2020 | 7 | 2020 |
| Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer BE Strauss, GRO Silva, I de Luna Vieira, OLD Cerqueira, PR Del Valle, ... Clinics 73 (suppl 1), e479s, 2018 | 7 | 2018 |
| Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget. 2017; 8 (41): 71249–84 RFV Medrano, A Hunger, SA Mendonca, JAM Barbuto, BE Strauss | 7 | |
| Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget 8, 71249–71284 RFV Medrano, A Hunger, SA Mendonca, JAM Barbuto, BE Strauss | 6 | 2017 |
| Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines. 2021; 6: 97 SA Mendonça, R Lorincz, P Boucher, DT Curiel DOI, 0 | 6 | |
| In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector R Lorincz, AB Alvarez, CJ Walkey, SA Mendonça, ZH Lu, AE Martinez, ... Biomedicine & Pharmacotherapy 158, 114189, 2023 | 4 | 2023 |
| Adenoviral vectors infect B lymphocytes in vivo PJ Rice-Boucher, SA Mendonça, AB Alvarez, AJ Sturtz, R Lorincz, ... Molecular Therapy 31 (9), 2600-2611, 2023 | 3 | 2023 |
| Induction of Immune-Stimulating Factors and Oncolysis Upon p14ARF Gene Transfer in Melanoma Cell Lines SA Mendonça, F Antunes, OLD Cerqueira, PR Del Valle, A Hunger, ... DNA and cell biology 42 (6), 274-288, 2023 | 3 | 2023 |
| Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy RFV Medrano, TA Salles, R Dariolli, F Antunes, VA Feitosa, A Hunger, ... Scientific Reports 12 (1), 13636, 2022 | 3 | 2022 |
| Abstract B39: Potentiation of doxorubicin low-dose efficacy through its association with p19Arf/Interferon-beta immunotherapy: Combining two immunogenic cell death inducers for … RFV Medrano Sr, SA Mendonca Sr, AH Ribeiro Sr, JPP Catani Sr, ... Clinical Cancer Research 24 (1_Supplement), B39-B39, 2018 | 1 | 2018 |
| Elucidating expression of a corrective enzyme for MPS I through administration of an adenoviral vector targeted to endothelial cells S Hurt, SQ Le, S Mendonça, A Sorensen, DT Curiel, PI Dickson Molecular Genetics and Metabolism 138 (2), 107161, 2023 | | 2023 |
| ENGINEERED ADENOVIRAL VECTORS EFFICIENTLY TRANSDUCE PRIMARY MURINE LYMPHOCYTES IN VITRO AND IN VIVO P Boucher, S Mendonca, D Curiel HUMAN GENE THERAPY 33 (7-8), A32-A32, 2022 | | 2022 |
| An adenoviral mediated gene therapy for mucopolysaccharidosis type I S Hurt, SQ Le, S Mendonca, P Dickson, DT Curiel Molecular Genetics and Metabolism 135 (2), S60, 2022 | | 2022 |
